Captrust Financial Advisors Integra Lifesciences Holdings Corp Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.14 - $34.72 $126,228 - $189,397	5,455 Added 30.45%	23,369 $680,000
Q1 2024 May 15, 2024	BUY	$33.4 - $45.2 $123,713 - $167,420	3,704 Added 26.07%	17,914 $635,000
Q4 2023 Feb 14, 2024	BUY	$34.21 - $44.59 $64,006 - $83,427	1,871 Added 15.16%	14,210 $618,000
Q3 2023 Nov 14, 2023	SELL	$37.8 - $45.97 $64,184 - $78,057	-1,698 Reduced 12.1%	12,339 $471,000
Q2 2023 Aug 14, 2023	BUY	$37.95 - $58.98 $123,868 - $192,510	3,264 Added 30.3%	14,037 $577,000
Q1 2023 May 15, 2023	SELL	$52.61 - $60.49 $5,892 - $6,774	-112 Reduced 1.03%	10,773 $618,000
Q4 2022 Feb 15, 2023	BUY	$42.17 - $58.6 $254,748 - $354,002	6,041 Added 124.71%	10,885 $610,000
Q3 2022 Nov 16, 2022	SELL	$42.28 - $57.17 $338 - $457	-8 Reduced 0.16%	4,844 $205,000
Q2 2022 Aug 23, 2022	SELL	$53.86 - $66.52 $24,021 - $29,667	-446 Reduced 8.42%	4,852 $262,000
Q2 2022 Aug 16, 2022	BUY	$53.86 - $66.52 $177,468 - $219,183	3,295 Added 164.5%	5,298 $286,000
Q1 2022 May 16, 2022	BUY	$62.86 - $69.24 $61,351 - $67,578	976 Added 95.03%	2,003 $129,000
Q4 2021 Feb 14, 2022	SELL	$62.47 - $73.25 $194,094 - $227,587	-3,107 Reduced 75.16%	1,027 $69,000
Q3 2021 Nov 16, 2021	BUY	$64.97 - $76.19 $17,217 - $20,190	265 Added 6.85%	4,134 $283,000
Q2 2021 Aug 16, 2021	SELL	$66.79 - $76.63 $3,940 - $4,521	-59 Reduced 1.5%	3,869 $264,000
Q1 2021 May 17, 2021	BUY	$62.63 - $71.15 $26,805 - $30,452	428 Added 12.23%	3,928 $271,000
Q4 2020 Feb 16, 2021	SELL	$43.31 - $66.55 $1,689 - $2,595	-39 Reduced 1.1%	3,500 $227,000
Q3 2020 Nov 17, 2020	BUY	$43.33 - $51.72 $49,872 - $59,529	1,151 Added 48.2%	3,539 $167,000
Q1 2020 May 15, 2020	BUY	$36.67 - $61.04 $87,567 - $145,763	2,388 New	2,388 $102,000
Q4 2019 Feb 14, 2020	SELL	$55.73 - $62.49 $113,967 - $127,792	-2,045 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$53.29 - $64.59 $6,128 - $7,427	-115 Reduced 5.32%	2,045 $123,000
Q2 2019 Aug 13, 2019	BUY	$46.45 - $55.85 $139 - $167	3 Added 0.14%	2,160 $121,000
Q1 2019 May 15, 2019	SELL	$42.97 - $57.33 $7,433 - $9,918	-173 Reduced 7.42%	2,157 $120,000
Q4 2018 Feb 13, 2019	BUY	$42.62 - $64.51 $30,132 - $45,608	707 Added 43.56%	2,330 $105,000
Q3 2018 Nov 15, 2018	BUY	$57.63 - $65.87 $749 - $856	13 Added 0.81%	1,623 $107,000
Q2 2018 Aug 13, 2018	BUY	$54.05 - $67.23 $10,755 - $13,378	199 Added 14.1%	1,610 $104,000
Q1 2018 May 15, 2018	SELL	$46.55 - $57.38 $21,785 - $26,853	-468 Reduced 24.91%	1,411 $76,000
Q4 2017 Feb 14, 2018	BUY	$46.22 - $51.77 $86,847 - $97,275	1,879	1,879 $90,000

Others Institutions Holding IART

# of Institutions

241

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

Black Rock Inc. New York, NY

11.3M
Shares

$249 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.74M
Shares

$172 Million
0.0% of portfolio
Morgan Stanley New York, NY

5.26M
Shares

$116 Million
0.01% of portfolio
Eaton Vance Management Boston, MA

4.22M
Shares

$93.4 Million
0.26% of portfolio
Fuller & Thaler Asset Management, Inc. San Mateo, CA

3.97M
Shares

$87.9 Million
0.29% of portfolio

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account